GB1051693A - - Google Patents
Info
- Publication number
- GB1051693A GB1051693A GB1051693DA GB1051693A GB 1051693 A GB1051693 A GB 1051693A GB 1051693D A GB1051693D A GB 1051693DA GB 1051693 A GB1051693 A GB 1051693A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydrogen
- compound
- give
- acyloxy
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 abstract 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 229930194542 Keto Natural products 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 210000004100 adrenal gland Anatomy 0.000 abstract 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 abstract 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 abstract 1
- 239000000292 calcium oxide Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000002009 diols Chemical class 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 229910000450 iodine oxide Inorganic materials 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
- BWHLPLXXIDYSNW-UHFFFAOYSA-N ketorolac tromethamine Chemical compound OCC(N)(CO)CO.OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 BWHLPLXXIDYSNW-UHFFFAOYSA-N 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- -1 triphenylphosphonium alkyl bromide Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1238021XA | 1962-07-09 | 1962-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1051693A true GB1051693A (enrdf_load_html_response) |
Family
ID=22410976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1051693D Active GB1051693A (enrdf_load_html_response) | 1962-07-09 |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE1238021B (enrdf_load_html_response) |
| GB (1) | GB1051693A (enrdf_load_html_response) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2013538A1 (enrdf_load_html_response) * | 1968-07-23 | 1970-04-03 | Hoechst Ag | |
| EP0348910A3 (en) * | 1988-06-28 | 1990-03-21 | Merrell Dow Pharmaceuticals Inc. | 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors |
| US11236074B2 (en) * | 2015-04-06 | 2022-02-01 | The Trustees Of The University Of Pennsylvania | Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject |
-
0
- GB GB1051693D patent/GB1051693A/en active Active
-
1963
- 1963-07-04 DE DES86003A patent/DE1238021B/de active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2013538A1 (enrdf_load_html_response) * | 1968-07-23 | 1970-04-03 | Hoechst Ag | |
| EP0348910A3 (en) * | 1988-06-28 | 1990-03-21 | Merrell Dow Pharmaceuticals Inc. | 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors |
| US11236074B2 (en) * | 2015-04-06 | 2022-02-01 | The Trustees Of The University Of Pennsylvania | Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject |
| US11987576B2 (en) | 2015-04-06 | 2024-05-21 | The Trustees Of The University Of Pennsylvania | Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1238021B (de) | 1967-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1380246A (en) | 3alpha-hydroxy-androstanes and esters thereof | |
| GB902294A (en) | Improvements in or relating to steroids and the manufacture thereof | |
| GB1051693A (enrdf_load_html_response) | ||
| GB1040554A (en) | The manufacture of 3-keto-19-alkyl-steroids | |
| GB1036415A (en) | 19-methylene-androstane derivatives and process for their production | |
| GB1060793A (en) | Improvements in or relating to steroids and the manufacture thereof | |
| US2934546A (en) | 6 alpha-fluoro steroids | |
| GB898295A (en) | Improvements in or relating to steroids and the manufacture thereof | |
| US2838532A (en) | 6-halo-17(20)-pregnenes | |
| US3684800A (en) | Di-epoxide process for the preparation of 9{60 -fluoro-16-methylene-prednisolone or-prednisone, and 21-esters thereof | |
| US3155695A (en) | 16-difluoromethyl adrenocorticoids | |
| GB897732A (en) | Cyclopentanophenanthrene derivatives | |
| GB906443A (en) | Steroid compounds | |
| US3092626A (en) | Process for the manufacture of 16-alkyl-20:21-ketols of the pregnane series | |
| US2773074A (en) | Process for the production of allopregnane-3beta, 11beta, 17alpha, 20beta, 21-pentols | |
| US2773887A (en) | Pregnane-11alpha, 17alpha-diol-3, 20-diones, esters thereof and process | |
| GB1050764A (enrdf_load_html_response) | ||
| GB1101116A (en) | Steroidal 2ª-carboxylic acids and esters | |
| GB918408A (en) | Esters of 21-hydroxy steroids and process for preparation | |
| GB921534A (en) | Cyclopentanophenanthrene derivatives and process for the production thereof | |
| ES395740A1 (es) | Procedimiento para la preparacion de nuevos 6 alfa. 16 alfa-dimetilesteroides. | |
| US3133914A (en) | Spiro-oxiranes of the pregnane series and methods for the manufacture thereof | |
| US2880215A (en) | 11alpha-lower alkyl steroids | |
| GB1037772A (en) | Improvements in or relating to í¸-steroid compounds | |
| GB773926A (en) | Improvements relating to pregnane compounds |